Evidence map›Paper›PMID 32193281›Full record

ArticleCMAJ open

Medically assisted reproduction and the risk of preterm birth: a case-control study using data from the Quebec Pregnancy Cohort.

Jessica Gorgui, Odile Sheehy, Jacquetta Trasler, William Fraser, Anick Bérard

Open access · diamondAbstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. A Compassion-Focused Approach to Support Parents After Preterm Birth.Clinical child and family psychology review · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jessica GorguiResearch Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
Odile SheehyResearch Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
Jacquetta TraslerResearch Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
William FraserResearch Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que.
Anick BérardResearch Centre (Gorgui, Sheehy, Bérard), Centre hospitalier universitaire Sainte-Justine; Faculty of Pharmacy (Gorgui, Bérard), University of Montréal; Departments of Pediatrics, Human Genetics and Pharmacology, and Therapeutics and Research Institute of the McGill University Health Centre (Trasler), McGill University, Montréal, Que.; Faculty of Medicine and Health Sciences (Fraser), University of Sherbrooke, Sherbrooke, Que. anick.berard@umontreal.ca.
Université de Montréal · CACentre Hospitalier Universitaire Sainte-Justine · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of fertility treatments has been growing over the past decade, but these treatments are not without risk. We aimed to quantify the risk of preterm birth associated with the use of ovarian stimulators (OS) and assisted reproductive technologies (ART) overall and by type of fertility treatment.

methodsWe conducted a case-control analysis of data from the Quebec Pregnancy Cohort. We included singleton pregnancies ending in a live birth during the time when Quebec operated a universal reimbursement program for assisted reproduction (2010-2015). Fertility treatments were defined dichotomously, and pregnancies resulting from spontaneous conception were used as the reference. We categorized fertility treatments into subgroups: ovarian stimulators alone, ART alone and OS and ART combined. Preterm birth was defined as birth before 37 weeks' gestation. We estimated odds ratios (ORs) for the association between type of assisted reproduction and preterm birth using generalized estimating equation models and adjusted ORs for potential confounders.

resultsA total of 57 624 pregnancies were included in the study. During the study period, 2055 pregnancies were conceived through the use of OS, ART or both: 419 involved OS alone, 150 involved ART alone and 1486 involved both OS and ART. When we adjusted for potential confounders, conception with OS, ART or both was associated with an increased risk of preterm birth (adjusted OR 1.46, 95% confidence interval [CI] 1.25-1.72, 182 exposed cases). All types of assisted reproduction were associated with an increased risk of preterm birth compared with pregnancies conceived spontaneously (OS alone: adjusted OR 1.47, 95% CI 1.04-2.07; ART alone: adjusted OR 1.76, 95% CI 1.01-3.06; OS and ART combined: adjusted OR 1.43, 95% CI 1.19-1.73). Use of OS or ART or both was associated with an increased risk of late, moderate and extremely preterm birth (extremely preterm birth: adjusted OR 2.39, 95% CI 1.30-4.39).

interpretationCompared with pregnancies conceived spontaneously, pregnancies conceived through the use of OS, ART or both were associated with a 46% increased risk of preterm birth. Physicians should advise patients of the increased risks of late, moderate and extremely preterm birth so that they can make informed choices.

Indexed as

AdultCase-Control StudiesComorbidityDisease SusceptibilityFemaleHumansInfant, NewbornMiddle AgedPregnancyPremature BirthPublic Health SurveillanceQuebecReproductive Techniques, AssistedRisk AssessmentRisk FactorsYoung Adult

Identifiers

PMID32193281
PMCPMC7089760
OpenAlexW3011677047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.